NOVO Nordisk Pharmaceuticals
has initiated a recall for product
correction of certain lots of its
NordiPen device, which is a nonsterile
re-usable injector pen
used with 5mg, 10mg and 15mg
Norditropin SimpleXx (somatropin)
human growth hormone cartridges.The above snippet is the first part of an article sent to subscribers in Pharmacy Daily's issue from 24 Jul 13 To see the full story, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 24 Jul 13
THE Pharmacy Guild of Australia has lodged a submission with the Fair Work Commission, in response to a “work value claim” seeking pharmacist pay rises made by union group APESMA as part of the Four Yearly Review of Modern Awards.
MEDLAB has confirmed that its Nanabis medicinal cannabis product is now ready for sale and delivery to Sydney’s Royal North Shore Hospital, where it will be part of an “intractable pain” trial commencing next month.